Canda, February 13, 2020 (420 INTEL)- Hemp is everywhere and according to various market studies, the entire industry is expected to be worth nearly $27 billion by 2025. There’s almost nothing that hemp can’t do. It can be used as a food supplement, medication, topical, it can be manufactured into …
Read More »investmentvaluefinders
Ontario Launches Consultations on Expanding Cannabis Business Opportunities
Canada, February 10, 2020 (ONTARIO)- Province Looking to Offer More Choice for Consumers and More Business Opportunities. The Ontario government is launching consultations in order to provide consumers more choice and convenience on cannabis while giving the private sector enhanced ability to compete against and combat the criminal market. “Ontario …
Read More »Peddler’s Licenses & Co-Ops: Chicago Brainstorms Ways to Make Cannabis More Equitable
U.S., February 5, 2020 (CANNABIS NOW)- A month into legal cannabis in Illinois, Chicago is considering various experimental models for cannabis cultivation and sales aimed at empowering those communities criminalized under prohibition. Cannabis became legal in Illinois on New Year’s Day, and now Chicago’s administration and community leaders are brainstorming …
Read More »The Connection Between Cannabis And Multiple Sclerosis
Canada, February 7, 2020 (420 INTEL)- One recent survey reported that upwards of 66% of those who suffer from MS may use cannabis in their efforts to control the disease. Multiple sclerosis, also known as MS, is a chronic autoimmune disease that affects the central nervous system (CNS) — brain and spinal cord — by damaging the fatty myelin …
Read More »Hemp in California: State to revisit legislation allowing CBD in food, beverages
U.S., February 6, 2020 (Hemp Industry Daily)- Hemp entrepreneurs in California are optimistic that long-awaited state legislation to legalize hemp-derived CBD as an ingredient in food, beverages and cosmetics will be revived from suspension and ready for Gov. Gavin Newsom to approve by spring. A coalition of hemp farmers, advocates and local …
Read More »FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC
TORONTO, Feb. 5, 2020 /CNW/ – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”) announces that Raza Bokhari, MD, Executive Co-Chairman and Chief Executive Officer, accompanied by FSD Pharma Biosciences leadership, will be participating in the 22nd Annual BIO CEO & Investor conference, including presenting a company overview at 9:45 a.m. ET on Monday, February 10, 2020. About …
Read More »Study Sheds Light On “Hot Hemp”
Australia, February 3, 2020 (HEMPGAZETTE)- Some widely held assumptions on THC levels in hemp have been put under the spotlight in a recent study. While hemp has far less of the intoxicating cannabinoid tetrahydrocannabinol (THC) than its cousin marijuana (low THC levels are what makes a cannabis sativa plant hemp …
Read More »Going Green(er): Environmental Initiatives in Cannabis
U.S., December 19, 2020 (Cannabis tech)- Cannabis may be known as the ‘green industry,’ but its reputation is not an exceptionally eco-friendly one. The industry has a bad rap for its inability to rein in excessive energy consumption, water needs, and waste issues all along the production cycle. When legal …
Read More »Processing Industrial Hemp
Due to the growth of the hemp industry, demand for specialized hemp processing equipment has surpassed the supply. U.S., January 25, 2020 (cannabis tech)- Due to the growth of the hemp industry, demand for specialized hemp processing equipment has surpassed the supply. As many entrepreneurs have discovered, finding machinery equipped …
Read More »FSD Pharma amends deal with Solarvest BioEnergy to accelerate progress of CBD project
U.S., February 4, 2020 (proactive)- The project is determining if its algal expression system can create pharmaceutical-grade cannabinoids. To enable Solarvest to accelerate the pace of the research, FSD Pharma has issued a further 225,371 of its shares FSD Pharma Inc (CSE:HUGE) (NASDAQ:HUGE), the specialty biotech, revealed it had amended its …
Read More »Disclaimer
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!